Jeremy Melmed is the DC, Maryland, and Virginia lead point of contact of Cresa’s International Life Sciences Practice Group. His technical skills, deep industry knowledge and intimate understanding of the local life sciences market has allowed him to develop world-class real estate solutions that are a competitive advantage for his clients. Jeremy works as an extension of his clients’ executive teams, providing them with strategic guidance to make highly informed real estate decisions.
1800 M Street
Washington, DC 20036
- Innovent Biologics
- Hansoh Pharmaceuticals
- Lifeline Cell Technology
- Viela Bio (acquired by Horizon Therapeutics)
Jeremy is a member of both the Commercial Real Estate Brokerage Association of Greater Washington, DC, and the U.S. Green Building Council, National Capital Region, respectively. In 2022, Jeremy was recognized by Cresa Global for his 2021 achievements with a Top Producer Award.